PRESS RELEASE published on 09/03/2024 at 14:20, 2 years ago Inside Information / Other news releases Arkema discloses trading in own shares from 26 to 28 August 2024, in line with regulations. Total volume acquired: 6,078 shares. More details on Arkema's website Shares Trading Buyback Regulations ARKEMA
PRESS RELEASE published on 09/03/2024 at 14:20, 2 years ago Informations privilégiées / Autres communiqués Arkema annonce les transactions sur actions propres effectuées du 26 au 28 août 2024, conformément à la réglementation. Consultez le site internet pour les détails Actions Propres Transactions Réglementation Site Internet ARKEMA
BRIEF published on 08/27/2024 at 11:53, 2 years ago Arkema Announces Share Buyback Transactions Share Buyback Trading Financial Disclosure ARKEMA August 2024
BRIEF published on 08/27/2024 at 11:53, 2 years ago Arkema annonce des opérations de rachat d'actions Rachat D'actions Divulgation Financière Commerce ARKEMA Août 2024
PRESS RELEASE published on 08/27/2024 at 11:48, 2 years ago Inside Information / Other news releases Arkema discloses share buyback transactions from 19 to 23 August 2024, in compliance with EU regulation. More details on the company's website Transactions Share Buyback Investor Relations EU Regulation ARKEMA
PRESS RELEASE published on 08/27/2024 at 11:48, 2 years ago Informations privilégiées / Autres communiqués Arkema déclare avoir réalisé des transactions sur actions propres conformément à la réglementation UE n°596/2014 du 19 au 23 août 2024 Actions Propres Transactions Achats ARKEMA Règlement UE N°596/2014
BRIEF published on 08/20/2024 at 11:37, 2 years ago Arkema Announces Share Buyback Transactions for August 2024 Share Buyback Investor Relations EU Regulations ARKEMA August 2024
BRIEF published on 08/20/2024 at 11:37, 2 years ago Arkema annonce des opérations de rachat d'actions pour août 2024 Rachat D'actions Relations Avec Les Investisseurs ARKEMA Règlements De L'UE Août 2024
PRESS RELEASE published on 08/20/2024 at 11:32, 2 years ago Inside Information / Other news releases Arkema discloses trading in own shares from 12 to 16 August 2024 in compliance with regulations. Total of 16,658 shares bought back. More details on Arkema's website Share Buyback Investor Relations Trading Compliance ARKEMA
PRESS RELEASE published on 08/20/2024 at 11:32, 2 years ago Informations privilégiées / Autres communiqués Arkema a déclaré les transactions sur actions propres réalisées du 12 août au 16 août 2024, conformément à la réglementation. Pour plus d'informations, veuillez consulter le site internet du groupe Actions Propres Transactions Investisseurs Rachats D'actions ARKEMA
Published on 09/11/2026 at 04:00, 5 hours 21 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 56 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 1 minute ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 21 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:05, 16 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 21 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 09:00, 21 minutes ago Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market
Published on 09/11/2026 at 07:00, 2 hours 21 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 21 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 21 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 51 minutes ago Availability of the 2026 Interim Financial Report
